ロード中...
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
Immunotherapy has revolutionized the treatment of both hematological malignancies and solid tumors. The use of immunotherapy has improved outcome for patients with cancer across multiple tumor types, including lung, melanoma, ovarian, genitourinary, and more recently breast cancer with durable respo...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228136/ https://ncbi.nlm.nih.gov/pubmed/32457830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00570 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|